Innovative patient monitoring solutions

A world without anesthesia and respiratory-related complications

Read more

Innovative portfolio of solutions

Senzime for investors

We are targeting a market opportunity valued more than SEK 40 billion per year.

NEWS: ExSpiron

Non-invasive, accurate, real-time respiratory volume monitoring

ExSpiron 2Xi enables non-invasive Respiratory Volume Monitoring (RVM), which has been demonstrated to provide the most direct measurement of respiratory status and the earliest indicator of changes in respiratory status.

NEWS: TetraSens Pediatric

State-of-the-art neuromuscular blockade monitoring for children

Every child deserves a safe anesthesia procedure. TetraSens Pediatric is a sensor array that is designed for the sensitive skin of a child and engineered to deliver the most accurate results, to provide ease of mind and confidence during any surgical procedure in any surgical position.

TetraSens Pediatric has FDA 510k-clearance and is CE marked.

A Swedish medical device company

Senzime develops, manufactures and markets CE- and FDA-cleared patient monitoring systems.

Our vision is a world without anesthesia and respiratory-related complications.

CEO Statement

Accelerating sales growth in the US and Europe, strategic partnership with global leader and acquisition in the US

Pia Renaudin

Press Releases

Explore our patient monitoring solutions

Get product details

How can Senzime’s products help to eliminate in-hospital complications?
Contact us to discuss your needs or schedule a product demo.